ARCHIVE

• DIAGNOSTIC NEWS IN BRIEF
  March 5, 2001

• Korosho to Deal with Biologics in Earnest
  March 5, 2001

• Korosho to Issue GL Regarding NAT for HBV, HCV, HIV
  March 5, 2001

• JPMA Invites Participation in Protein Structure Analysis Consortium
  March 5, 2001

• 39 New Drugs Approved in 2000: PMSB
  March 5, 2001

• Individual Health Insurance Cards to Be Introduced in April
  March 5, 2001

• JPMA Calls For Maintenance of NHI Price Listing by Brand Name
  March 5, 2001

• GL for Investigational Use of ES Cells Proposed
  March 5, 2001

• Kemporen Proposes Series of Measures to Contain Medical Spending
  March 5, 2001

• Fujisawa Ties Up with Fuji RC for Respiratory Care Devices
  March 5, 2001

• Dissolution Test Methods Proposed for 13 Active Ingredients
  March 5, 2001

• MIC Receives Applications for Clinical Trials via Toll-free Dial
  March 5, 2001

• Nomura Securities Starts Nomura Bio Network
  March 5, 2001

• CORPORATE ROUNDUP NEWS IN BRIEF
  March 5, 2001

• Novartis: Group Sales Up 10% to CHF 35.8 Bil.
  March 5, 2001

• 60% of Manufacturer-hired MRs Are Interested in Contract MRs
  March 5, 2001

• Korosho to Present Drug Pricing Reform Policy by Summer
  March 5, 2001

• Raloxifene Reduces Risk of Breast Cancer
  March 5, 2001

• BULLETIN
  March 5, 2001

• Government Takes Measures against Stevens-Johnson Syndrome
  March 5, 2001

ページ

• « 先頭
• ‹ Prev
• …
• 772
• 773
• 774
• 775
• 776
• 777
• 778
• 779
• 780
• …
• Next ›
• 最終 »